Viewing Study NCT00472927


Ignite Creation Date: 2025-12-25 @ 5:08 AM
Ignite Modification Date: 2025-12-26 @ 4:12 AM
Study NCT ID: NCT00472927
Status: COMPLETED
Last Update Posted: 2007-12-06
First Post: 2007-05-10
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Bioequivalence Study of 3 New Formulations of Premarin/MPA Compared With Premarin/MPA (Prempro)
Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module